Month: <span>January 2019</span>

Home / 2019 / January
Post

Coaxing’ stem cells to form new bone tissue

New research has identified a possible way to manipulate certain stem cells to generate new bone tissue. The results of this investigation could vastly improve the outcome for people with skeletal injuries or conditions such as osteoporosis. Stem cells are undifferentiated cells that have the potential to specialize and undertake any function. Image: A new study looks at how to encourage stem cells to form new bone tissue rather than...

Post

Study overturns dogma of cancer metabolism theory

Scientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have discovered that squamous cell skin cancers do not require increased glucose to power their development and growth, contrary to a long-held belief about cancer metabolism. Image shows squamous cell skin cancer tumors with lactate production (a byproduct of glucose...

Post

Scientists design protein that prods cancer-fighting T-cells

The new immunotherapy drug is designed to fight cancer while avoiding common side effects. This illustration depicts how the new protein, in red, binds only to the beta and gamma receptors, and not to cells with a third kind of receptor. (version with labels) Credit: Institute for Protein Design Scientists at UW Medicine’s Institute for...

Post

Scientists discover cocktail of cancer medication and plant-based supplement could halt body’s decline

Anti-ageing drug derived from a compound in green tea, onions and RED WINE is on the horizon: Scientists discover cocktail of cancer medication and plant–based supplement could haltbody’s decline Zombie – or senescent – cells are alive but do not function properly Cell removal improved the ability to walk in patients with deadly lung disease ‘Glimmer’ drug cocktail may work for other ’20 diseases’ linked to zombie cells An...

Post

Expression of a molecule in blood cells predicts atherosclerosis risk

The receptor CD69 protects against the formation of atherosclerotic plaques CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III (F.S.P.) Earlier detection of cardiovascular disease is a step closer thanks to the findings of a research team at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) led by Francisco Sánchez-Madrid and Pilar Martín. The scientists have found that...

Post

UTSA uncovers the disconnect between the brain’s dopamine system and cocaine addiction

UNIVERSITY OF TEXAS AT SAN ANTONIO (San Antonio, Jan. 10, 2019) — Researchers at The University of Texas at San Antonio have revealed significant insight into cocaine addiction, a phenomenon which has grown significantly in the United States since 2015. Now new data by UTSA shows how the release of the neurotransmitter dopamine changes when...

Post

Modulating copper levels in the treatment of heart disease

An article published in Experimental Biology and Medicine provides new insights regarding the use of trientine (TETA), a copper chelator traditionally used to treat copper overload conditions such as Wilson’s disease, in the treatment of heart disease. The study, led by Dr. Y. James Kang, professor from the Regenerative Medicine Research Center at Sichuan University...

Post

Blood pressure may explain higher dementia risk in blacks

Older black adults with high blood pressure, and especially black men, show more severe cognitive declines than white adults who have high blood pressure, according to new research. The University of Michigan-led study published Wednesday in the American Heart Association’s journal Hypertension, suggests blood pressure may help explain why black adults—who are more likely to...

Post

Drug may delay MS disability for some

The medication is called rituximab (Rituxan). It’s used to treat a number of conditions, including certain blood cell cancers and the autoimmune condition rheumatoid arthritis. The new Swiss study found that MS patients taking the drug reported less disabling symptoms over a 10-year period than those who didn’t. People taking rituximab also had a slower...